###begin article-title 0
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
OPCML Is a Broad Tumor Suppressor for Multiple Carcinomas and Lymphomas with Frequently Epigenetic Inactivation
###end article-title 0
###begin p 1
Conceived and designed the experiments: YC YY QT. Performed the experiments: YC YY KMN QT. Analyzed the data: AH JY QZ JJ DL JR SYR ML AC GS GT GS JJS DS. Contributed reagents/materials/analysis tools: AH JY QZ JJ DL JR SYR ML AC GS GT GS JJS DS. Wrote the paper: YC YY QT.
###end p 1
###begin p 2
Current address: Wyeth Research, Translational Medicine Research Collaboration, Dundee, United Kingdom
###end p 2
###begin title 3
Background
###end title 3
###begin p 4
###xml 261 267 261 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML,</italic>
Identification of tumor suppressor genes (TSGs) silenced by CpG methylation uncovers the molecular mechanism of tumorigenesis and potential tumor biomarkers. Loss of heterozygosity at 11q25 is common in multiple tumors including nasopharyngeal carcinoma (NPC). OPCML, located at 11q25, is one of the downregulated genes we identified through digital expression subtraction.
###end p 4
###begin title 5
Methodology/Principal Findings
###end title 5
###begin p 6
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 670 675 670 675 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Semi-quantitative RT-PCR showed frequent OPCML silencing in NPC and other common tumors, with no homozygous deletion detected by multiplex differential DNA-PCR. Instead, promoter methylation of OPCML was frequently detected in multiple carcinoma cell lines (nasopharyngeal, esophageal, lung, gastric, colon, liver, breast, cervix, prostate), lymphoma cell lines (non-Hodgkin and Hodgkin lymphoma, nasal NK/T-cell lymphoma) and primary tumors, but not in any non-tumor cell line and seldom weakly methylated in normal epithelial tissues. Pharmacological and genetic demethylation restored OPCML expression, indicating a direct epigenetic silencing. We further found that OPCML is stress-responsive, but this response is epigenetically impaired when its promoter becomes methylated. Ecotopic expression of OPCML led to significant inhibition of both anchorage-dependent and -independent growth of carcinoma cells with endogenous silencing.
###end p 6
###begin title 7
Conclusions/Significance
###end title 7
###begin p 8
###xml 52 57 52 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Thus, through functional epigenetics, we identified OPCML as a broad tumor suppressor, which is frequently inactivated by methylation in multiple malignancies.
###end p 8
###begin title 9
Introduction
###end title 9
###begin p 10
###xml 114 117 114 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Baylin1">[1]</xref>
###xml 338 341 338 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jones1">[2]</xref>
###xml 542 545 542 545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Belinsky1">[3]</xref>
Epigenetic silencing of tumor suppressor genes (TSGs) is frequently involved in tumor development and progression [1]. Aberrant methylation of promoter CpG islands (CGI) represents a major mechanism of this epigenetic inactivation, which leads to the binding of transcription repressors, compressed chromatin, and transcription silencing [2]. Identification of candidate TSGs silenced by promoter methylation thus uncovers the epigenetic mechanism of carcinogenesis and also identifies new epigenetic tumor markers for early cancer detection [3].
###end p 10
###begin p 11
###xml 131 134 131 134 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tao1">[4]</xref>
###xml 244 247 244 247 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-RaabTraub1">[5]</xref>
###xml 249 252 249 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tao2">[6]</xref>
###xml 325 328 325 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tao1">[4]</xref>
###xml 444 447 444 447 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">BLU</italic>
###xml 452 459 452 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASSF1A</italic>
###xml 468 471 468 471 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Qiu1">[7]</xref>
###xml 473 476 473 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Lo1">[8]</xref>
###xml 478 489 478 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CADM1/TSLC1</italic>
###xml 501 504 501 504 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Lung1">[9]</xref>
###xml 506 515 506 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">THY1/CD90</italic>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Lung2">[10]</xref>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH1</italic>
###xml 549 553 549 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Chang1">[11]</xref>
###xml 555 561 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RASAL1</italic>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin1">[12]</xref>
###xml 567 575 567 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ADAMTS18</italic>
###xml 580 585 580 585 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CDH13</italic>
###xml 595 599 595 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin2">[13]</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sun1">[14]</xref>
###xml 209 227 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 229 232 <span type="species:ncbi:10376">EBV</span>
Nasopharyngeal carcinoma (NPC) is a prevalent tumor in Southern China and Southeast Asia, particularly in the Cantonese population [4]. Although virtually all NPC has been shown to be strongly associated with Epstein-Barr virus (EBV) infection [5], [6], the molecular mechanism of NPC pathogenesis is still poorly elucidated [4]. Searches for putative TSGs have identified only few candidates, with tumor-specific promoter methylation, such as BLU and RASSF1A at 3p21 [7], [8], CADM1/TSLC1 at 11q23.1 [9]; THY1/CD90 at 11q22.3 [10], CDH1 at 16q22.1 [11], RASAL1[12], ADAMTS18 and CDH13 at 16q23 [13], [14]. These limited findings suggest that additional candidate TSGs are yet to be identified for this tumor.
###end p 11
###begin p 12
###xml 373 382 373 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 403 408 403 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 482 487 482 487 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OBCAM</italic>
###xml 708 712 708 712 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Wilson1">[15]</xref>
###xml 713 717 713 717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Eagleson1">[18]</xref>
###xml 774 778 774 778 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-McNamee1">[19]</xref>
###xml 798 803 798 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1001 1005 1001 1005 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sellar1">[20]</xref>
###xml 1050 1055 1050 1055 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1100 1104 1100 1104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tsou1">[21]</xref>
###xml 1156 1160 1156 1160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Wang1">[22]</xref>
###xml 1162 1166 1162 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Reed1">[23]</xref>
We previously used a new strategy to search for candidate TSGs genome-wide in NPC, through combining Differential Gene Expression Displayer (DGED) analysis with reported loss of heterozygosity (LOH) data of NPC (Liu & Tao, manuscript in preparation). This strategy revealed a number of putative TSGs that were down-regulated in NPC and also located at LOH loci. One of the in silico identified genes is OPCML (opioid binding protein/cell adhesion molecule-like gene), also known as OBCAM (opioid binding cell adhesion molecule), belonging to the IgLON (OPCML, LSAMP, NEGR1 and HNT) family of glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecules that are highly expressed in the nervous system [15]-[18] and involved in cell adhesion and cell-cell recognition [19]. Located at 11q25, OPCML was the first IgLON member linked to tumorigenesis. It was initially identified as a TSG for epithelial ovarian cancer, being frequently inactivated by hemizygous deletion and promoter methylation [20]. More recent studies also demonstrated that OPCML is highly methylated in lung adenocarcinoma [21] and down-regulated in gastric and brain carcinomas [22], [23], however no study has been reported for NPC and other tumors yet.
###end p 12
###begin p 13
###xml 116 121 116 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 121 125 121 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Reed1">[23]</xref>
###xml 149 154 149 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSAMP</italic>
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Pimenta1">[24]</xref>
###xml 501 506 501 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 784 789 784 789 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
We thus systematically studied its alteration in a series of common tumors. As alternative splicing is a feature of OPCML[23] and other IgLONs (e.g. LSAMP) [24], we first studied its alternative splicing. We then examined its epigenetic inactivation in NPC and multiple other tumors which have not been studied for this gene, including esophageal, lung, gastric, hepatocellular, colorectal, breast, cervical and prostate carcinomas, as well as non-Hodgkin and Hodgkin lymphomas. We further found that OPCML is a stress- and p53-responsive gene; however, its stress response is epigenetically disrupted when the promoter becomes methylated. Ectopic expression of OPCML in tumor cell lines with endogenous silencing led to strong inhibition of cell colony formation, demonstrating that OPCML acts as a broad tumor suppressor.
###end p 13
###begin title 14
Results
###end title 14
###begin title 15
Identification of novel splicing variants of OPCML
###end title 15
###begin p 16
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 71 78 71 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1A</xref>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 155 158 155 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNT</italic>
###xml 204 209 204 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1B</xref>
###xml 468 472 468 472 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Reed1">[23]</xref>
###xml 376 381 <span type="species:ncbi:9606">human</span>
OPCML contains 7 exons and is transcribed from telomere to centromere (Fig. 1A). Among the four IgLON family members, OPCML shares the highest homology to HNT that lies approximately 80 kb centromeric to OPCML in the opposite orientation. Two alternative splice transcripts of OPCML, variant 1 (v1) (NM_002545) and variant 2 (v2) (NM_001012393), were previously identified in human, which differ only in their 5' exons (Fig. 1B) but encode an identical mature protein [23].
###end p 16
###begin title 17
###xml 45 50 45 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 80 85 <span type="species:ncbi:9606">human</span>
Identification of novel splicing variants of OPCML and its expression in normal human tissues.
###end title 17
###begin p 18
###xml 69 74 69 74 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 79 82 79 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNT</italic>
###xml 198 203 198 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 301 306 301 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 470 475 470 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 527 532 527 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 792 797 792 797 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1032 1037 1032 1037 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1202 1207 1202 1207 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1278 1283 1278 1283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1345 1350 1345 1350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1488 1493 1488 1493 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1509 1514 1509 1514 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1600 1605 1600 1605 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1719 1724 1719 1724 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1818 1823 1818 1823 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1051 1056 <span type="species:ncbi:9606">human</span>
(A) Genomic organization of the 11q25 locus with the two known genes OPCML and HNT. Transcriptional orientations are shown by curved arrows. (B) Different promoter usage and alternative splicing of OPCML. Alternative mRNA transcripts are shown aligned from 5' to 3' on a virtual genome. The 5'-end of OPCML-v1 assembled by ECgene (Genome Annotation for Alternative Splicing, ) was adapted to this alignment. (C) Left panel: determination of transcription start sites of OPCML transcripts by 5'-RACE. Right panel: expression of OPCML-v1 and v3 in brain and testis by semi-quantitative RT-PCR using 5'-RACE product as the template. Primer pair v1F/R4 amplifies one band that is specific to v1. Primer pair v1F0/R4 amplifies two bands corresponding to v1 and v3, respectively. (D) Expression of OPCML-v1 and v3 in adult tissues by semi-quantitative RT-PCR. Primer pair v1F0/R4 amplifies two bands corresponding to v1 and v3, respectively. The specific and non-specific bands have been confirmed by direct sequencing. (E) Expression of OPCML-v1 and v2 in human normal adult and fetal tissues. Primer pair v1F/R4, v2F/R4 and F3/R2 are specific to the v1-, v2-transcripts, and common exons (exon 2 and 3) of OPCML , respectively. Sk.M., skeletal muscle. (F) Possible transcription of OPCML from other unidentified alternative promoters. Expression of OPCML in normal and tumor cell lines was analyzed by semi-quantitative RT-PCR using primers (F3/R2) specific to common exons (exon 2 and 3) of OPCML. Expression of OPCML-v1 or v2 is indicated as "+", while downregulation or silencing is indicated as "-". OPCML-v1 promoter methylation status in each cell line is also shown. M, methylated; U, unmethylated. Transcription of OPCML from unknown alternative promoters was found in some tumor cell lines (underlined) where the OPCML-v1 promoter is methylated and silenced and v2 expression is also silenced.
###end p 18
###begin p 19
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 186 193 186 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1C</xref>
###xml 603 628 591 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1B and 1C left panel</xref>
###xml 1027 1046 1003 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1C right panel</xref>
###xml 1271 1278 1247 1254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1D</xref>
###xml 1359 1364 1335 1340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1500 1507 1476 1483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1F</xref>
###xml 108 113 <span type="species:ncbi:9606">human</span>
We determined the transcription start sites of OPCML using 5'-Rapid Amplification of cDNA Ends (5'-RACE) in human brain and testis RNA. We obtained four PCR products of different sizes (Fig. 1C). Sequence analysis of the major PCR product (EU562296) indicated it as the v2 variant. The 5' end of v2 was found to be shorter (approximately110-bp downstream) than the published data, but its transcription start site matched exactly the DBTSS prediction (DataBase of Transcriptional Start Sites, ). Three minor splice forms were also identified, designated v4 (EU562298), v5 (EU562299), and v6 (EU562300) (Fig. 1B and 1C left panel). Our 5'-RACE gel electrophoresis failed to reveal a PCR band for the major transcript variant v1 in brain and testis tissues, probably due to the presence of a too large exon 1 (approximately1-kb) for v1, which would result in low amplification efficiency. Thus, we performed further RT-PCR using the 5'-RACE product of brain and testis as template and primers specific to v1 (v1F/R4 and v1F0/R4; Fig. 1C right panel), to check whether v1 was expressed in normal tissues. This analysis did confirm the expression of v1 (EU562295) and identified another alternatively spliced variant v3 (EU562297) which is widely expressed in adult tissues (Fig. 1D). Further analysis using primers specific to the common exons (exon 2 and 3) of OPCML variants in cell lines without both v1 and v2 transcripts revealed the presence of even more unidentified, alternative promoter usage (Fig. 1F).
###end p 19
###begin title 20
Broad expression of OPCML-v1 and v2 major variants in normal tissues
###end title 20
###begin p 21
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 91 95 91 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sellar1">[20]</xref>
###xml 276 283 276 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1B</xref>
###xml 300 305 300 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 604 611 604 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1E</xref>
###xml 630 635 630 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 890 895 890 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 145 150 <span type="species:ncbi:9606">human</span>
Previously, OPCML was shown to be strongly expressed in brain and normal ovarian epithelia [20]. We further assessed its expression in 33 normal human adult and fetal tissues by semi-quantitative PCR with specific primers targeting the v1, v2, or common exons (exon 2 and 3) (Fig. 1B), respectively. OPCML-v1 was widely expressed in all normal adult and fetal tissues except for placenta and peripheral blood mononuclear cells (PBMC), though at varying levels (highly expressed in brain, kidney, spleen, stomach, trachea, testis, cervix, ovary and prostate, and weakly in lung, breast, and bone marrow) (Fig. 1E). Compared to v1, OPCML-v2 displayed a more tissue-specific expression pattern in adult tissues, with expression absent or barely detectable in kidney, spleen, pancreas, breast, testis, lung, colon, liver, testis and bone marrow. In contrast to its expression in adult tissues, OPCML-v2 was expressed at moderate to high levels in all fetal tissues except for placenta. These results suggest that both v1 and v2 are likely to have important functions in embryonic development.
###end p 21
###begin title 22
Silencing of OPCML by CpG methylation in tumor cell lines
###end title 22
###begin p 23
###xml 14 19 14 19 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 53 62 53 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in silico</italic>
###xml 218 223 218 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 462 469 462 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g002">Fig. 2C</xref>
###xml 474 483 474 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002990.s002">Figure S1</xref>
###xml 529 536 529 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g002">Fig. 2D</xref>
###xml 864 869 864 869 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 927 932 927 932 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1162 1167 1162 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
We identified OPCML as a down-regulated gene through in silico subtraction. We further validated its expression in a large collection of carcinoma and lymphoma cell lines by semi-quantitative RT-PCR. It was found that OPCML-v1 expression was dramatically reduced or completely silenced in multiple carcinoma cell lines of nasopharynx, esophagus, breast, cervix, stomach, lung, colon, liver and prostate, as well as in virtually all lymphoma cell lines examined (Fig. 2C and Figure S1), but readily detected in glioma cell lines (Fig. 2D). In contrast, its expression was readily detected in most non-tumor cell lines, including normal mammary (HMEC, HMEpC) and prostate (PrEC-6) epithelial cell line, and immortalized but non-transformed epithelial cell lines (nasopharyngeal, NP69; esophageal, NE1, NE3 and Het-1A; prostate, MLCSV40). Thus, the downregulation of OPCML-v1 appeared to be tumor-specific. Notably, expression of OPCML-v2 remained undetectable in virtually all cell lines evaluated, including normal cell lines. Given its limited tissue expression pattern and the fact that v2 promoter is not a CpG island with very few CpG sites, the mechanism of OPCML-v2 silencing is not pursued further in the current study.
###end p 23
###begin title 24
###xml 27 32 27 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Epigenetic inactivation of OPCML in multiple tumor cell lines.
###end title 24
###begin p 25
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 967 972 967 972 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
(A) Schematic structure of the v1 (NM_002545) CGI, with its exon 1, predicted promoter region, MSP region and BGS region indicated. Each short vertical line represents one CpG site. The v2 promoter is also shown. (B) Validation of the specificity of the MSP system. No signal was detected using the unbisulfited DNA from several tumor cell lines. (C) Representative analyses of OPCML v1 and v2 (NM_001012393) expression by semi-quantitative RT-PCR and methylation status of v1-CGI by MSP in tumor cell lines and normal controls. M, methylated; U, unmethylated. Immortalized normal epithelial cell lines (NE1, NE3, Het-1A, NP69, CCD 841, MLCSV40) and normal epithelial cell lines (HMEC, HMEpC and PrEC-6) with underlined names were used as normal controls. RC170N/h and RC165N/h are telomerase-immortalized benign prostate epithelial cell lines, RC92a/h and RC58T/h/SA#4 are telomerase-immortalized prostate tumor derived cell lines. (D) Expression and methylation of OPCML in glioma cell lines.
###end p 25
###begin p 26
###xml 91 94 91 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jones1">[2]</xref>
###xml 185 190 185 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 406 411 406 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 550 557 550 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g002">Fig. 2A</xref>
###xml 855 860 855 860 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1006 1013 1006 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g002">Fig. 2B</xref>
###xml 1047 1052 1047 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1085 1094 1085 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002990.s003">Figure S2</xref>
###xml 1407 1414 1407 1414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g002">Fig. 2C</xref>
###xml 1416 1425 1416 1425 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002990.s002">Figure S1</xref>
###xml 1430 1437 1430 1437 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002990-t001">Table 1</xref>
###xml 1607 1614 1607 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g002">Fig. 2C</xref>
###xml 354 362 <span type="species:ncbi:274808">Searcher</span>
As methylation of promoter CGI is a well-recognized epigenetic mechanism of TSGs silencing [2], we thus examined the potential promoter regions of the 2 major variants (v1 and v2). The OPCML-v1 (NM_002545) and v2 (NM_001012393) sequence upstream of their exon 1 was retrieved from the NCBI database and analyzed using promoterinspector () and CpG Island Searcher (). This analysis predicted a promoter for OPCML-v1, located within a typical CGI spanning the published transcription start site of v1, which was also confirmed by our 5'-RACE analysis (Fig. 2A). We did not find any obvious CGI or predicted promoter in the region upstream of the exon 1 of v2, indicating that either the v2 promoter is not a typical one or the published 5'-end sequence of v2 is not complete yet. Thus, we focused on the role of promoter CGI methylation in the silencing of OPCML-v1. We first validated that our methylation-specific PCR (MSP) was specific, which did not give any non-specific signal for the unbisulfate DNA (Fig. 2B) and revealed the methylation of OPCML-v1 in silenced placenta tissue (Figure S2). Next, v1 promoter methylation was detected in most tumor cell lines with downregulated or silenced expression (6/6 nasopharyngeal, 15/17 esophageal, 5/5 lung, 17/17 gastric, 11/11 colorectal, 6/13 hepatocellular, 9/10 breast, 8/8 cervical and 2/3 prostate carcinoma cell lines, and 20/21 lymphoma cell lines) (Fig. 2C, Figure S1 and Table 1), while no methylation was detected in the eight normal epithelial cell lines, demonstrating that v1 promoter methylation is well correlated with its expression status (Fig. 2C).
###end p 26
###begin title 27
###xml 11 16 11 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Summary of OPCML methylation in cell lines and primary tumors.
###end title 27
###begin p 28
###xml 459 465 459 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g003">Fig. 3</xref>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
To further confirm the MSP results and examine the methylation status of the v1 CGI in more detail, we performed high-resolution bisulfite genome sequencing (BGS) analysis of 90 CpG sites within the island, spanning almost the entire predicted promoter. The BGS results were consistent with the MSP analysis, with all the promoter alleles extensively methylated in silenced cell lines and only scattered methylated CpG sites detected in non-tumor cell lines (Fig. 3). These results thus revealed a strong correlation between OPCML-v1 promoter methylation and its transcriptional silencing in tumor cell lines.
###end p 28
###begin title 29
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
High-resolution methylation analysis of the OPCML-v1 promoter by BGS.
###end title 29
###begin p 30
###xml 795 799 791 795 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sellar1">[20]</xref>
A region spanning the promoter with 90 CpG sites was analyzed. Each CpG site is shown at the top row as an individual number. Dense methylation of the v1-CGI was found in ESCC (EC18, EC109) and NPC (C666-1, CNE2, HK1) cell lines, but not in normal esophageal (NE1, NE3) and nasopharyngeal epithelial (NP69) cell lines. Five to 8 colonies of cloned BGS-PCR products from each bisulfite-treated DNA sample were sequenced and each is shown as an individual row, representing a single allele of the CGI analyzed. One circle indicates one CpG site. Dark filled or open circles represent methylated or unmethylated CpG sites, respectively. Delta indicates possible variation of a CpG site to the CpA or CpT dinucleotides. The MSP region in this study and the BGS region studied in the previous report [20] are indicated in frames. The rightmost column is the MSP result of each sample.
###end p 30
###begin title 31
Pharmacologic and genetic demethylation restored OPCML-v1 expression
###end title 31
###begin p 32
###xml 51 56 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 355 360 355 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g004">Fig. 4A</xref>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 610 615 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNMT1</italic>
###xml 620 626 620 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNMT3B</italic>
###xml 643 647 643 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Rhee1">[25]</xref>
###xml 649 656 649 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g004">Fig. 4B</xref>
###xml 793 800 793 800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g004">Fig. 4C</xref>
###xml 838 843 838 843 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 871 876 871 876 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNMT1</italic>
###xml 881 887 881 887 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNMT3B</italic>
###xml 909 918 909 918 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bona-fide</italic>
###xml 957 961 957 961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin1">[12]</xref>
###xml 963 967 963 967 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin2">[13]</xref>
###xml 969 973 969 973 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ying1">[26]</xref>
###xml 990 995 990 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1070 1081 1070 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g004">Fig. 4A, 4B</xref>
###xml 1118 1123 1118 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
To determine whether methylation directly mediates OPCML silencing, carcinoma and lymphoma cell lines (MB231, Hep3B, HepG2, SNU398, SW480 and L1236) were treated with the DNA methyltransferase inhibitor 5-aza-2'-deoxycytidine (Aza), together with or without histone deacetylase inhibitor Trichostatin A (TSA). The treatment resulted in the restoration of OPCML-v1 expression in all tumor cell lines (Fig. 4A). OPCML-v1 could also be induced in the colorectal cancer cell line HCT116 which is completely methylated for this gene, by genetic demethylation through double knock-out of both DNA methyltransferases DNMT1 and DNMT3B (DKO cell line) [25] (Fig. 4B). Concomitantly, the v1 promoter alleles were almost completely demethylated in DKO cells as confirmed by high-resolution BGS analysis (Fig. 4C), suggesting that the maintenance of OPCML methylation is mediated by DNMT1 and DNMT3B together, like other bona-fide TSGs that we and others have examined [12], [13], [26]. Interestingly, OPCML-v2 could not be activated in any drug treated cell line or DKO cell line (Fig. 4A, 4B), suggesting that the expression of OPCML-v2, being tissue-specific, is controlled by other intrinsic mechanism(s), and that its silencing in multiple carcinoma cell lines is controlled by methylation-independent mechanism or, less likely, that its upregulation level is below the limit of detection.
###end p 32
###begin title 33
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Restorations of OPCML-v1 expression by demethylation.
###end title 33
###begin p 34
###xml 83 88 83 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 104 109 104 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 212 217 212 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 256 261 256 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 327 332 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNMT1</italic>
###xml 337 344 337 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">DNMT 3B</italic>
###xml 423 428 423 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
(A) Pharmacological demethylation by Aza (A) and TSA (T) induced the expression of OPCML-v1 but not v2. OPCML expression before and after drug treatment was determined by RT-PCR. (B) Genetic demethylation of the OPCML-v1 CGI also activated its expression. OPCML-v1 expression in HCT116 cells and HCT116 with double knockout of DNMT1 and DNMT 3B (DKO) are shown. (C) Detailed BGS analysis confirmed the demethylation of the OPCML-v1 CGI in DKO cells.
###end p 34
###begin title 35
OPCML downregulation was not due to genetic deletion
###end title 35
###begin p 36
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 174 179 174 179 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 233 237 233 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sellar1">[20]</xref>
###xml 306 311 306 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 481 487 481 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g005">Fig. 5</xref>
###xml 611 615 611 615 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin1">[12]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ying1">[26]</xref>
###xml 623 627 623 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Seng1">[27]</xref>
###xml 664 669 664 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
The downregulation of OPCML in multiple tumor cell lines might also result from genetic deletion, as it resides in the frequently deleted 11q25 locus. Hemizygous deletion of OPCML was also often detected in epithelial ovarian cancer [20]. We thus performed multiplex differential genomic DNA PCR to detect OPCML deletion for a region spanning the frequently deleted marker D11S4085 in epithelial ovarian cancer. No homozygous deletion was detected in any silenced tumor cell line (Fig. 5). Furthermore, our high-resolution 1-Mb array comparative genomic hybridization (aCGH) analysis of NPC and ESCC cell lines [12], [26], [27] revealed the hemizygous deletion of OPCML in only 2 out of 15 cell lines (data not shown). Thus, downregulation of OPCML appears not to be due to genetic deletion, but rather predominantly to epigenetic silencing.
###end p 36
###begin title 37
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Analysis of homozygous deletion of OPCML in multiple carcinoma cell lines and normal controls.
###end title 37
###begin p 38
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
The abundance of OPCML relative to GAPDH was determined by multiplex differential genomic DNA PCR. The expression of OPCML in each sample is also shown. +, normal expression; -, downregulated/silenced.
###end p 38
###begin title 39
Frequent methylation of OPCML in multiple primary tumors
###end title 39
###begin p 40
###xml 28 33 28 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 151 158 151 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g006">Fig. 6A</xref>
###xml 163 170 163 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0002990-t001">Table 1</xref>
###xml 173 178 173 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1059 1066 1059 1066 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g006">Fig. 6A</xref>
###xml 1124 1129 1124 1129 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1252 1259 1252 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g006">Fig. 6B</xref>
###xml 566 574 <span type="species:ncbi:9606">patients</span>
We further investigated the OPCML-v1 promoter methylation in a large collection of primary tumors, some with corresponding normal tissues as controls (Fig. 6A and Table 1). OPCML-v1 methylation was detected in 98% (42/43) of NPC, 66% (21/32) of esophageal, 91% (10/11) of breast, 64% (7/11) of gastric, 94% (17/18) of colorectal, 57% (4/7) of hepatocellular and 88% (7/8) of cervical carcinomas, as well as in 100% (10/10) of Burkitt lymphoma and 89% (8/9) of nasal lymphoma. Methylation was also detected with low frequency in paired surgical marginal tissues from patients with esophageal carcinoma at the rate of 16% (5/32), and with breast carcinoma at the rate of 25% (1/4), which might be due to the presence of small number of tumor cells disseminated into the adjacent non-tumorious region or an early tumor in the adjacent normal regions. Basically no methylation was detected in normal epithelial tissues (nasopharynx, esophagus and breast) except for very weak methylation in three nasopharyngeal, two esophageal and one breast epithelial tissues (Fig. 6A). These results further demonstrated that methylation of OPCML-v1 promoter is frequent in multiple tumors. In contrast, no methylation was detected in all five prostate cancer samples (Fig. 6B).
###end p 40
###begin title 41
OPCML-v1 was also methylated in different primary tumors.
###end title 41
###begin p 42
###xml 32 37 32 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 303 307 303 307 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Hoque1">[44]</xref>
(A) Frequent methylation of the OPCML-v1 CGI in multiple primary tumors as analyzed by MSP. M, methylated; U, unmethylated. Representative results are shown. T, tumors; N, paired non-tumor tissues. Good quality of bisulfited DNA samples of normal NPx (NPx1-4) has been confirmed by Q-MSP for beta-actin [44]. (B) In contrast, no methylation was detected in prostate tumors. EsCa, esophageal carcinoma; HCC, hepatocellular carcinoma; GsCa, gastric carcinoma; BrCa, breast carcinoma; CxCa, cervical carcinoma.
###end p 42
###begin title 43
Promoter methylation disrupted the stress response of OPCML-v1
###end title 43
###begin p 44
###xml 19 24 19 24 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 156 163 156 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g007">Fig. 7A</xref>
###xml 200 205 200 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 271 276 271 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 427 428 427 428 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 429 430 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 556 563 556 563 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g007">Fig. 7B</xref>
###xml 581 586 581 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Examination of the OPCML promoter revealed multiple HSF and p53 binding elements (MatInspector, ), indicating that it is a stress- and p53-responsive gene (Fig. 7A). We thus inspected the response of OPCML to environmental stress stimuli. We found that the expression of OPCML-v1 was dramatically elevated in cell lines with an unmethylated promoter, after exposure to various stresses, such as heat shock, UV irradiation and H2O2 treatment. On the contrary, this response was significantly decreased or abolished in cell lines with a methylated promoter (Fig. 7B). Interestingly, OPCML-v2 was not activated in any stress-treated cell line, indicating that it is not stress-responsive, probably due to its tissue-specific expression feature.
###end p 44
###begin title 45
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
The OPCML-v1 promoter is stress- and p53-responsive.
###end title 45
###begin p 46
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 372 373 366 367 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 374 375 368 369 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 388 393 382 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 605 609 599 603 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Seng1">[27]</xref>
###xml 625 630 619 624 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 730 735 724 729 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
(A) Locations of transcription factors (HSF, p53, Sp1, E2F, STAT) binding sites in the promoter are indicated. (B) Up-regulation of OPCML-v1 in response to stress treatments is disrupted in tumor cell lines with a methylated promoter. Normal (NE3, HEK293, NE1) and tumor cell lines (Rael, CNE1, C666-1, HK1) were exposed to 42degreesC heat shock (HS), UV irradiation, or H2O2 treatments. OPCML-v1 promoter methylation status in each cell line is shown at the bottom. M, methylated; U, unmethylated. (C) H1299 cells were transfected with different amounts of pcDNA3.1+/TP53 (gift from Dr. Bert Vogelstein) [27]. Expression of OPCML-v1 and v2 was analyzed by semi-quantitative RT-PCR. p53 induced a dosage-dependent upregulation of OPCML-v1.
###end p 46
###begin p 47
###xml 17 22 17 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 125 132 125 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g007">Fig. 7C</xref>
###xml 183 188 183 188 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
p53 could induce OPCML expression in the H1299 cell line with a partially methylated promoter, in a dosage-dependent manner (Fig. 7C). Taken together, these results demonstrated that OPCML is a stress-responsive and p53-regulated gene but its stress response is impaired by promoter methylation.
###end p 47
###begin title 48
Ectopic expression of OPCML-v1 inhibited tumor cell clonogenicity
###end title 48
###begin p 49
###xml 26 31 26 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 132 137 132 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 329 334 329 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 496 501 496 501 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 515 522 515 522 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g002">Fig. 2C</xref>
###xml 779 793 779 793 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g008">Fig. 8A and 8C</xref>
###xml 958 972 958 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g008">Fig. 8B and 8C</xref>
###xml 981 986 981 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
The frequent silencing of OPCML-v1 in multiple tumor cell lines and primary tumors but not normal epithelial tissues indicates that OPCML-v1 is likely a tumor suppressor. We thus sought to establish whether ectopic expression of OPCML-v1 could inhibit tumor cell clonogenicity. A mammalian expression vector encoding full-length OPCML-v1 was transfected into colorectal (HCT116), esophageal (KYSE510) and prostate (PC3) carcinoma cell lines which had completely methylated and silenced endogeous OPCML-v1 promoter (Fig. 2C). The colony formation efficiencies of transfected cell line were evaluated by monolayer and soft agar culture. Ectopic expression of OPCML-v1 significantly inhibited the anchorage-dependent growth of three cell lines (down to 30%-60% of vector controls) (Fig. 8A and 8C). Meanwhile, a significant reduction of colony formation efficiencies was observed in anchorage-independent growth of HCT116 cells (down to 30% of vector control) (Fig. 8B and 8C). Thus, OPCML-v1 indeed has growth inhibitory activities in tumor cells and can function as a tumor suppressor.
###end p 49
###begin title 50
Ectopic expression of OPCML-v1 inhibits tumor cell growth.
###end title 50
###begin p 51
###xml 194 199 194 199 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 564 565 562 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
The effect of ectopic OPCML-v1 expression on carcinoma cell clonogenicity was investigated by monolayer colony formation assay (A) and soft agar assay (B). Cells were transfected with pcDNA3.1+/OPCML-v1 or control vector, and selected with G418. (C) Quantitative analyses of colony formation. The numbers of G418-resistant colonies in each vector-transfected control were set to 100%, while OPCML-v1 expressed cells were presented as mean+/-SD. Three independent experiments were performed in triplicate. The asterisk indicated statistical significant difference (p<0.01).
###end p 51
###begin title 52
Discussion
###end title 52
###begin p 53
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 187 192 187 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 352 357 352 357 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 506 511 506 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 661 666 661 666 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
We used a novel approach of combining DGED screening for down-regulated genes with reported LOH data of NPC to search for silenced candidate TSGs genome-wide in NPC and identified OPCML. OPCML is frequently silenced by promoter methylation rather than genetic deletion in NPC, as well as multiple other carcinomas and lymphomas. We further showed that OPCML is a stress-responsive and p53-regulated gene, with the response abrogated when the promoter becomes methylated. In addition, ectopic expression of OPCML in carcinoma cells lacking its expression led to dramatic anchorage-dependent and -independent growth inhibition. Thus, our results demonstrate that OPCML is a broad functional tumor suppressor that is epigenetically silenced in multiple tumors.
###end p 53
###begin p 54
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 527 531 527 531 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Funatsu1">[17]</xref>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Lodge1">[28]</xref>
###xml 539 543 539 543 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Gil2">[29]</xref>
###xml 728 732 728 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-McNamee1">[19]</xref>
###xml 824 828 824 828 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Reed2">[30]</xref>
###xml 859 864 859 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 955 959 955 959 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Shark1">[31]</xref>
###xml 1022 1026 1022 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sellar1">[20]</xref>
###xml 1091 1095 1091 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Harpaz1">[32]</xref>
###xml 1120 1125 1120 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1257 1262 1257 1262 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1462 1466 1462 1466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sellar1">[20]</xref>
###xml 1524 1529 1524 1529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">LSAMP</italic>
###xml 1576 1580 1576 1580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Chen1">[33]</xref>
###xml 1622 1627 1622 1627 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1851 1856 1851 1856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1966 1970 1966 1970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Reed2">[30]</xref>
###xml 459 462 <span type="species:ncbi:10116">rat</span>
###xml 467 472 <span type="species:ncbi:9031">chick</span>
OPCML belongs to the IgLON family of immunoglobulin (Ig) domain containing glycosylphosphatidylinositol (GPI)-anchored cell adhesion molecules, which includes OPCML, LSAMP, NEGR1 and HNT. The IgLON proteins are highly conserved between species and are typically composed of three Ig domains tethered to the surface of cell membrane by anchoring of their hydrophobic tails to GPI. Limited knowledge about the functions of IgLONs mainly derives from studies in rat and chick brain, the tissues where they are primarily expressed [17], [28], [29]. In those studies, IgLONs have been suggested to play an important role in cell adhesion and cell-cell recognition, through both homo- and hetero-philic interactions within the family [19]. Recently, it has been proposed that IgLONs function mainly as heterodimers called Diglons [30]. As a cell adhesion molecule, OPCML comprises several protein-protein interaction domains, such as three 'C2' like Ig domains [31] which are more appropriately classified as 'I' set Ig domains [20], commonly found in cell-surface-adhesion and receptor molecules [32]. Through these domains, OPCML may bind directly to growth promoting or inhibitory molecules and modulate their functions in tumor cells. Among the IgLON family, OPCML was the first member reported to possess tumor suppressor functions in epithelial ovarian cancer, being frequently silenced genetically and epigenetically at the early step of ovarian carcinogenesis [20]. This was followed by another report that another IgLON, LSAMP, is also a TSG for renal clear cell carcinoma [33]. Our present study further verifies that OPCML can function as a broad TSG and is frequently inactivated epigenetically in multiple carcinomas and lymphomas, including NPC, esophageal, lung, gastric, hepatocellular, colorectal, breast, cervical and prostate carcinomas. OPCML probably functions as a tumor suppressor through interacting with other IgLONs to form heterodimeric complex [30] involved in signal transduction. Loss of OPCML reduces the intercellular adhesion and heterodimeric complex formation and thus impairs the corresponding signaling pathways, thereby promoting the progress of carcinogenesis.
###end p 54
###begin p 55
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 37 40 37 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNT</italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 131 134 131 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNT</italic>
###xml 377 382 377 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HNT</italic>
OPCML shares the highest homology to HNT among the four IgLON family members. Notably, the coding region in exon 1 of OPCML-v1 and HNT is identical, and so is the exon 2 except for only several bases. The first Ig domains of these two proteins share 92% identity, while the second and third Ig domains share 70% and 66% identity, respectively. This raises the possibility that OPCML and HNT may originate from the same ancestor by gene conversion during evolution. Thus, primers must be cautiously designed for these two genes to avoid cross-amplification with PCR-based techniques.
###end p 55
###begin p 56
###xml 29 34 29 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 108 113 108 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 163 168 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 440 445 440 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 727 732 727 732 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 800 805 800 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 839 846 839 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g001">Fig. 1F</xref>
###xml 877 882 877 882 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Our results also reveal that OPCML transcripts v1 and v2 have different tissue expression patterns. Whereas OPCML-v1 was widely expressed in normal adult tissues, OPCML-v2 showed a more tissue-specific expression profile, being highly expressed in few tissues including brain. Previously, a genome-wide searching for the neuron specific silencer REST/NRSF binding sites (RE1/NRSE) revealed that there were three NRSE located at intron 1 of OPCML-v2 (), suggesting that v2 may be a more neuron specific transcript. We also identified other novel isoforms of OPCML (v3, v4, v5, v6), derived from alternative splicing or promoter usages. Using primers specific to the common exons of OPCML transcripts, we found the expression of OPCML in several tumor cell lines (Hep3B, H292, SW480, L1236), where the OPCML-v1 and v2 were totally silenced (Fig. 1F), indicating transcription of OPCML from alternative unknown promoters. Our present study mainly focused on the expression and functional analysis of transcript variant 1, whereas the mechanism of variant 2 silencing was not pursued further. Further studies are needed to characterize these novel splicing variants, their promoter usages and possible biologic functions.
###end p 56
###begin p 57
###xml 90 93 90 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jones1">[2]</xref>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 235 240 235 240 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 398 403 398 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 563 568 563 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 712 717 712 717 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 892 897 892 897 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPMCL</italic>
###xml 1071 1077 1071 1077 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0002990-g003">Fig. 3</xref>
Epigenetic gene silencing is associated with the onset and progression of various cancers [2]. The frequent, predominant epigenetic inactivation of OPCML in multiple malignancies points to the importance of this gene in tumorigenesis. OPCML is a stress- and p53-responsive gene, but this response was often epigenetically impaired by promoter methylation. We speculate that epigenetic silencing of OPCML would impair the cellular protective response to environmental stresses in normal cells, thus promoting the development of cancers. As promoter methylation of OPCML was pharmacologically and genetically reversible, pharmacologic demethylation therapy will restore its response to stress and p53. The role of OPCML in DNA damage repair, apoptosis and cell cycle arrest with respect to stress response remains to be further investigated. We also noticed that in some cell lines (like HCC), OPMCL-v1 was silenced without promoter methylation detected by MSP. It could be that for some cell lines, the methylation is not evenly distributed through the CGI (like HepG2 in Fig. 3) and is thus missed by MSP analysis, or additional alternative mechanism such as histone modification is involved.
###end p 57
###begin p 58
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 304 309 304 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 418 423 418 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 504 509 504 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
In summary, we found that the expression of OPCML-v1 (NM_002545), a major transcript of this TSG, is frequently silenced or down-regulated in multiple tumors. This inactivation is due to its promoter methylation, which further impairs its response to environmental stresses. We further demonstrated that OPCML acts as a broad tumor suppressor for multiple tumor types. The high incidence of epigenetic inactivation of OPCML in NPC and esophageal carcinoma, both prevalent in our locality, indicates that OPCML methylation could be an epigenetic biomarker for the molecular diagnosis of these tumors.
###end p 58
###begin title 59
Materials and Methods
###end title 59
###begin title 60
Cell lines, tumor and normal tissue samples
###end title 60
###begin p 61
###xml 334 338 334 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin1">[12]</xref>
###xml 340 344 340 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin2">[13]</xref>
###xml 346 350 346 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ying1">[26]</xref>
###xml 525 529 525 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tsao1">[34]</xref>
###xml 609 613 609 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ying1">[26]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Deng1">[35]</xref>
###xml 770 773 770 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 780 783 780 783 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 853 857 853 857 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Rhee1">[25]</xref>
###xml 995 999 995 999 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tao3">[36]</xref>
###xml 1089 1093 1089 1093 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ying1">[26]</xref>
###xml 361 365 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
A series of tumor cell lines were studied, including nasopharyngeal-NPC, esophageal, lung, gastric, colorectal, hepatocellular, breast, cervical and prostate carcinomas, glioma, Hodgkin and non-Hodgkin lymphomas, including Burkitt lymphoma (BL), diffuse large B-cell lymphoma (DLBCL), T-cell lymphoma (TL) and NK/T-cell lymphoma (NL) [12], [13], [26]. NP69, an SV40 T-antigen-immortalized nasopharyngeal epithelial cell line with many features of normal nasopharyngeal epithelial cells was used as a 'normal' control for NPC [34]. Three immortalized normal esophageal epithelial cell lines (NE1, NE3, Het-1A) [26], [35] were used as 'normal' controls for esophageal carcinoma. Colon HCT116 cell lines with double knock-out of DNA methyltransferases (DNMTs): HCT116 DNMT1-/- DNMT3B-/- (DKO) cells (gifts from Dr Bert Vogelstein, Johns Hopkins) were used [25]. Total RNA and DNA were extracted from cell pellets using TRI Reagent (Molecular Research Centre, Cincinnati, OH) as reported previously [36]. Cell lines were treated with Aza (Sigma, St. Louis, MO) and TSA as described previously [26].
###end p 61
###begin p 62
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ying1">[26]</xref>
###xml 320 324 320 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Srivastava1">[37]</xref>
###xml 326 330 326 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Wong1">[38]</xref>
###xml 464 467 464 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Qiu1">[7]</xref>
###xml 469 473 469 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Jin1">[12]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Seng1">[27]</xref>
###xml 481 485 481 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tao3">[36]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ai1">[39]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Steenbergen1">[43]</xref>
###xml 0 5 <span type="species:ncbi:9606">Human</span>
###xml 156 161 <span type="species:ncbi:9606">Human</span>
Human normal adult and fetal tissue RNA samples were purchased commercially (Stratagene, La Jolla, CA, USA or Millipore Chemicon, Billerica, MA, USA) [26]. Human normal tissue DNA samples were purchased from BioChain Institute (Hayward, CA). DNA samples of normal esophageal epithelial tissues were described previously [37], [38]. DNA samples from various primary carcinomas and their corresponding surgical marginal normal tissues (N), were described previously [7], [12], [27], [36], [39]-[43].
###end p 62
###begin title 63
Digital expression subtraction
###end title 63
###begin p 64
We searched for downregulated genes genome-wide through Differential Gene Expression Displayer (DGED) analysis (cDNA DGED and SAGE DGED) (). This analysis identified a number of downregulated genes in tumors. The candidate gene list was further filtered with the reported loss of heterozygosity (LOH) data of NPC. Genes located at published LOH regions in NPC were extracted using UCSC genome database ().
###end p 64
###begin title 65
5'-Rapid Amplification of cDNA Ends (5'-RACE)
###end title 65
###begin p 66
###xml 18 23 18 23 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 175 198 175 198 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TCCAGGTACTCATCCTCACT</named-content>
###xml 380 403 380 403 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-CTGCCAATAGCAAGACACAG</named-content>
###xml 513 536 513 536 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">5&#8242;-TATGGACCACTTGTCATTCC</named-content>
We determined the OPCML transcription start site using 5'-RACE version 2.0 (Invitrogen). Briefly, the first-strand cDNA was synthesized from brain RNA using primer OPCML-DxR, 5'-TCCAGGTACTCATCCTCACT. Homopolymeric tails were then added to the 3'ends with terminal deoxynucleotidyl transferase. PCR was done using Abridged Anchor Primer and a second gene-specific primer OPCML-R2, 5'-CTGCCAATAGCAAGACACAG. The RACE product was enriched by reamplifying with the Abridged Universal Amplification Primer and OPCML-R, 5'-TATGGACCACTTGTCATTCC, cloned and sequenced.
###end p 66
###begin title 67
Semi-quantitative RT-PCR analysis
###end title 67
###begin p 68
###xml 96 99 96 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 162 167 162 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 181 185 181 185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tao3">[36]</xref>
###xml 306 314 306 314 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002990.s001">Table S1</xref>
Reverse transcription-PCR (RT-PCR) was performed for 36 or 37 cycles with hot-start, using AmpliTaq Gold DNA Polymerase (Applied Biosystems, Foster City, CA) and GAPDH as a control [36]. RT-PCR primers were designed to span introns to prevent amplification of genomic DNA. Primer sequences are provided in Table S1.
###end p 68
###begin title 69
Bisulfite treatment and promoter methylation analysis
###end title 69
###begin p 70
###xml 142 146 142 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Ying1">[26]</xref>
###xml 148 152 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Tao3">[36]</xref>
###xml 211 214 211 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Taq</italic>
###xml 467 475 467 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002990.s001">Table S1</xref>
Bisulfite modification of DNA, methylation-specific PCR (MSP) and bisulfite genomic sequencing (BGS) were carried out as previously described [26], [36]. Both MSP and BGS were performed for 40 cycles using AmpliTaq Gold with hot-start. MSP primers were tested first for not amplifying any unbisulfited DNA. For BGS, the PCR products were cloned into pCR4-TOPO (Invitrogen, Carlsbad, CA), with 5-8 colonies randomly chosen and sequenced. Primer sequences are shown in Table S1.
###end p 70
###begin title 71
Stress treatments
###end title 71
###begin p 72
###xml 44 47 44 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Qiu1">[7]</xref>
###xml 342 343 330 331 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 467 468 449 450 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 469 470 451 452 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 515 516 497 498 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 517 518 499 500 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Heat shock was done as previously described [7], except for an incubation at 42degreesC for 1 hour with recovery at 37degreesC for 2 hours. For UV treatment, medium was removed and the flask was turned upside down to face the light source in a UV cross-linker (Amersham Biosciences, Piscataway, NJ). Cells were irradiated for a dose of 70 J/m2. After irradiation, fresh medium was added, and the cells were recovered at 37degreesC for 1 hour and then harvested. For H2O2 treatment, cells were exposed to 0.5 mM of H2O2 for 1 hour and then harvested.
###end p 72
###begin title 73
Deletion analysis of OPCML by multiplex PCR
###end title 73
###begin p 74
###xml 98 101 98 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Qiu1">[7]</xref>
###xml 133 141 133 141 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0002990.s001">Table S1</xref>
###xml 170 175 170 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 180 185 180 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
Homozygous deletion of OPCML was examined using multiplex genomic DNA PCR as previously described [7]. Primer sequences are shown in Table S1. The final concentration of OPCML and GAPDH primers is 0.4 microM and 0.2 microM, respectively. PCR products were analyzed on 1.8% agarose gels.
###end p 74
###begin title 75
Colony formation assays
###end title 75
###begin p 76
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 65 70 65 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 79 83 79 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0002990-Sellar1">[20]</xref>
###xml 123 128 123 128 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 183 184 183 184 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 307 312 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
###xml 1190 1191 1182 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 816 822 <span type="species:ncbi:9913">bovine</span>
###xml 900 906 <span type="species:ncbi:9913">bovine</span>
The full-length OPCML-v1 ORF was subcloned from the pcDNA3.1 Zeo/OPCML plasmid [20] into pcDNA3.1(+) to generate pcDNA3.1+/OPCML-v1. HCT-116, KYSE510 and PC3 cells were seeded at 1x105/well in a 12-well plate and allowed to grow for 24h. Cells were then transiently transfected with 0.5 microg of pcDNA3.1+/OPCML-v1 or pcDNA 3.1 vector alone, using Fugene6.0 (Roche, Switzerland). For colony formation assay using monolayer culture, cells were collected and plated in a 6-well plate 48h post-transfection, and selected for 1 to 2 weeks with G418 (0.4mg/ml). Surviving colonies (>/=50 cells/colony) were counted after staining with Gentian Voilet (ICM Pharma, Singapore). For colony formation assay using soft agar culture, at 48h post-transfection, cells were suspended in RPMI 1640 containing 0.35% agar, 10% fetal bovine serum and 0.4 mg/ml G418 and layered on RPMI containing 0.5% agar, 10% fetal bovine serum and G418 in a 6-well plate. Colonies were photographed at day 20 post-transfection. All the experiments were performed in triplicate wells for three times. Data were presented as relative colony formation ability+/-SD. Statistical analysis was carried out by Student's t-test, p<0.01 was considered as statistically significant difference.
###end p 76
###begin title 77
Supporting Information
###end title 77
###begin p 78
PCR primers used in this study.
###end p 78
###begin p 79
(0.07 MB DOC)
###end p 79
###begin p 80
Click here for additional data file.
###end p 80
###begin p 81
###xml 30 35 30 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML</italic>
Expression and methylation of OPCML in Hodgkin and non-Hodgkin lymphoma cell lines.
###end p 81
###begin p 82
(0.17 MB TIF)
###end p 82
###begin p 83
Click here for additional data file.
###end p 83
###begin p 84
###xml 26 34 26 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OPCML-v1</italic>
Methylation status of the OPCML-v1 in multiple normal adult and fetal tissues as analyzed by MSP.
###end p 84
###begin p 85
(0.11 MB TIF)
###end p 85
###begin p 86
Click here for additional data file.
###end p 86
###begin p 87
We thank Bert Vogelstein, George Tsao, Michael Obster, Soh-ha Chan, (Dolly Huang), Kai-Tai Yao, Ya Cao, Gui-yuan Li, Renske DM Steenbergen, Vivian Lui, Maria Lung, Shuen-Kuei Liao for some cell lines and samples, and DSMZ (German Collection of Microorganisms & Cell Cultures) for the KYSE cell lines (Shimada et al., Cancer 69: 277-284 (1992).
###end p 87
###begin title 88
References
###end title 88
###begin article-title 89
Epigenetic gene silencing in cancer - a mechanism for early oncogenic pathway addiction?
###end article-title 89
###begin article-title 90
The fundamental role of epigenetic events in cancer.
###end article-title 90
###begin article-title 91
Gene-promoter hypermethylation as a biomarker in lung cancer.
###end article-title 91
###begin article-title 92
Nasopharyngeal carcinoma: molecular pathogenesis and therapeutic developments.
###end article-title 92
###begin article-title 93
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Epstein-Barr virus in the pathogenesis of NPC.
###end article-title 93
###begin article-title 94
###xml 0 18 <span type="species:ncbi:10376">Epstein-Barr virus</span>
###xml 20 23 <span type="species:ncbi:10376">EBV</span>
###xml 44 49 <span type="species:ncbi:9606">human</span>
Epstein-Barr virus (EBV) and its associated human cancers-genetics, epigenetics, pathobiology and novel therapeutics.
###end article-title 94
###begin article-title 95
The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
###end article-title 95
###begin article-title 96
High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
###end article-title 96
###begin article-title 97
TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma.
###end article-title 97
###begin article-title 98
THY1 is a candidate tumour suppressor gene with decreased expression in metastatic nasopharyngeal carcinoma.
###end article-title 98
###begin article-title 99
###xml 173 180 <span type="species:ncbi:9606">patient</span>
Evaluation of hypermethylated tumor suppressor genes as tumor markers in mouth and throat rinsing fluid, nasopharyngeal swab and peripheral blood of nasopharygeal carcinoma patient.
###end article-title 99
###begin article-title 100
###xml 124 129 <span type="species:ncbi:9606">human</span>
Epigenetic silencing of a Ca(2+)-regulated Ras GTPase-activating protein RASAL defines a new mechanism of Ras activation in human cancers.
###end article-title 100
###begin article-title 101
Epigenetic identification of ADAMTS18 as a novel 16q23.1 tumor suppressor frequently silenced in esophageal, nasopharyngeal and multiple other carcinomas.
###end article-title 101
###begin article-title 102
Aberrant methylation of CDH13 gene in nasopharyngeal carcinoma could serve as a potential diagnostic biomarker.
###end article-title 102
###begin article-title 103
A family of glycoproteins (GP55), which inhibit neurite outgrowth, are members of the Ig superfamily and are related to OBCAM, neurotrimin, LAMP and CEPU-1.
###end article-title 103
###begin article-title 104
Neurotrimin mediates bifunctional effects on neurite outgrowth via homophilic and heterophilic interactions.
###end article-title 104
###begin article-title 105
###xml 28 31 <span type="species:ncbi:10116">rat</span>
Characterization of a novel rat brain glycosylphosphatidylinositol-anchored protein (Kilon), a member of the IgLON cell adhesion molecule family.
###end article-title 105
###begin article-title 106
Distinct domains of the limbic system-associated membrane protein (LAMP) mediate discrete effects on neurite outgrowth.
###end article-title 106
###begin article-title 107
Promotion of neuronal cell adhesion by members of the IgLON family occurs in the absence of either support or modification of neurite outgrowth.
###end article-title 107
###begin article-title 108
OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer.
###end article-title 108
###begin article-title 109
Identification of a panel of sensitive and specific DNA methylation markers for lung adenocarcinoma.
###end article-title 109
###begin article-title 110
###xml 102 110 <span type="species:ncbi:9606">patients</span>
Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.
###end article-title 110
###begin article-title 111
Expression of cellular adhesion molecule 'OPCML' is down-regulated in gliomas and other brain tumours.
###end article-title 111
###begin article-title 112
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Characterization of the genomic structure of the mouse limbic system-associated membrane protein (Lsamp) gene.
###end article-title 112
###begin article-title 113
###xml 47 52 <span type="species:ncbi:9606">human</span>
DNMT1 and DNMT3b cooperate to silence genes in human cancer cells.
###end article-title 113
###begin article-title 114
Functional epigenetics identifies a protocadherin PCDH10 as a candidate tumor suppressor for nasopharyngeal, esophageal and multiple other carcinomas with frequent methylation.
###end article-title 114
###begin article-title 115
The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
###end article-title 115
###begin article-title 116
###xml 100 105 <span type="species:ncbi:9031">chick</span>
Co-localisation, heterophilic interactions and regulated expression of IgLON family proteins in the chick nervous system.
###end article-title 116
###begin article-title 117
Complementary expression and heterophilic interactions between IgLON family members neurotrimin and LAMP.
###end article-title 117
###begin article-title 118
Diglons are heterodimeric proteins composed of IgLON subunits, and Diglon-CO inhibits neurite outgrowth from cerebellar granule cells.
###end article-title 118
###begin article-title 119
###xml 75 80 <span type="species:ncbi:9606">human</span>
Cloning, sequencing and localization to chromosome 11 of a cDNA encoding a human opioid-binding cell adhesion molecule (OBCAM).
###end article-title 119
###begin article-title 120
Many of the immunoglobulin superfamily domains in cell adhesion molecules and surface receptors belong to a new structural set which is close to that containing variable domains.
###end article-title 120
###begin article-title 121
The t(1;3) breakpoint-spanning genes LSAMP and NORE1 are involved in clear cell renal cell carcinomas.
###end article-title 121
###begin article-title 122
###xml 77 81 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Establishment of two immortalized nasopharyngeal epithelial cell lines using SV40 large T and HPV16E6/E7 viral oncogenes.
###end article-title 122
###begin article-title 123
###xml 122 127 <span type="species:ncbi:9606">human</span>
Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines.
###end article-title 123
###begin article-title 124
Defective de novo methylation of viral and cellular DNA sequences in ICF syndrome cells.
###end article-title 124
###begin article-title 125
###xml 35 53 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Coinfection of multiple strains of Epstein-Barr virus in immunocompetent normal individuals: reassessment of the viral carrier state.
###end article-title 125
###begin article-title 126
Aberrant promoter hypermethylation and silencing of the critical 3p21 tumour suppressor gene, RASSF1A, in Chinese oesophageal squamous cell carcinoma.
###end article-title 126
###begin article-title 127
Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.
###end article-title 127
###begin article-title 128
###xml 4 22 <span type="species:ncbi:10376">Epstein-Barr virus</span>
The Epstein-Barr virus major latent promoter Qp is constitutively active, hypomethylated, and methylation sensitive.
###end article-title 128
###begin article-title 129
###xml 26 44 <span type="species:ncbi:10376">Epstein-Barr virus</span>
Methylation status of the Epstein-Barr virus major latent promoter C in iatrogenic B cell lymphoproliferative disease. Application of PCR-based analysis.
###end article-title 129
###begin article-title 130
The stress-responsive gene GADD45G is a functional tumor suppressor, with its response to environmental stresses frequently disrupted epigenetically in multiple tumors.
###end article-title 130
###begin article-title 131
TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia.
###end article-title 131
###begin article-title 132
Genome-wide promoter analysis uncovers portions of the cancer methylome.
###end article-title 132
###begin p 133
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 133
###begin p 134
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: This project was supported by a Hong Kong RGC Central Allocation Grant (CA06/07.SC03 to QT) and a Chinese University of Hong Kong direct grant.
###end p 134

